The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository

Part of paid clinical trials in Nashville, Tennessee.

Sponsor
Vanderbilt-Ingram Cancer Center
Study ID
NCT06701214
Status
Recruiting
Apply to this trial

Conditions

  • Clonal Hematopoiesis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Blood collection — OTHER
    Blood will be taken from participants already undergoing blood collection
  • Saliva collection — OTHER
    Undergo saliva collection
  • Bone marrow collection — OTHER
    Bone marrow will be taken from participants already undergoing bone marrow collection

Study Details

This study will investigate the association between clonal hematopoiesis and other conditions. Clonal hematopoiesis (CH) refers to the mutations in a person's stem cells which commonly affect people as they get older. These mutations have notably been linked to increased risk of certain cancers as well as increased risk of heart disease.

Key Dates

Start date
Oct 28, 2020
Status verified
Nov 2024
Primary completion
Nov 30, 2030
Completion
Nov 30, 2031

Study Design

Enrollment
800 participants (estimated)

Primary Outcome Measure

CHIVE Registry [ Time Frame: Up to approximately 120 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Vanderbilt University/Ingram Cancer CenterNashvilleTennessee37203
Vanderbilt-Ingram Service Services for Timely Access
[email protected]
800-811-8480
Alexander Bick, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Nashville, TN

By research site
Vanderbilt University/Ingram Cancer Center· Nashville, TN

Related Studies